Trial-based cost-effectiveness analysis of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) versus DSAEK.

Rob W P Simons Mor M DickmanFrank J H M van den BiggelaarCarmen D DirksenJeroen Van RooijLies RemeijerAllegonda Van der LelijRobert H J WijdhPieter J KruitRudy M M A Nuijts

Published in: Acta ophthalmologica (2019)

The base case analysis favoured DSAEK, since costs of UT-DSAEK were higher while QALYs were comparable. However, additional analyses revealed no preference for UT-DSAEK or DSAEK. Further cost-effectiveness studies are required to reduce uncertainty.

Keyphrases

clinical trial
study protocol
deep learning
endothelial cells
high throughput
phase ii
open label
double blind